Inotiv Inc (NOTV)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$0.01-26.00%
Close 2026-07-17 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
Warn: Primary pillar under pressure — Address Nasdaq delisting notice and regain listing compliance: Nasdaq compliance not resolved; stock at $0.01 vs delisting threshold.
Inotiv aims to restructure through Chapter 11 to reduce debt and reorganize. The company has a plan to manage accelerated financial obligations triggered by bankruptcy. If successful, it could stabilize operations and address Nasdaq delisting risks. This could eventually restore some value for shareholders.
Inotiv has filed for bankruptcy and faces delisting from Nasdaq. Earnings are negative with a mean EPS of -$0.52 next quarter and -$2.37 for fiscal 2026. The company is loss-making with elevated risk and no clear path to profitability. The restructuring may fail, leading to further value destruction.
The market is pricing in a distressed scenario with bankruptcy and delisting risks. There is no consensus revenue growth or fair value estimate available, reflecting uncertainty. Our view aligns with the market on the high risk and weak fundamentals but remains open to upside if restructuring succeeds.
Breaks if: Failure to exit Chapter 11 within 12 months or restructuring plan collapse
Complete the Chapter 11 bankruptcy reorganization process to address financial and operational challenges.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a turnaround investment focused on a company undergoing Chapter 11 proceedings. The current thesis state is cautious, as the company is dealing with financial distress and mixed management priorities.
The market appears to be pricing in elevated risks due to the company's loss-making status and recent financial performance, which is below that of its peers. Expectations seem to reflect uncertainty around its ability to stabilize and recover.
Fundamentals are likely to remain weak in the near term, given the high probability of an earnings miss and ongoing financial pressures. The company's recent results show declining revenue and increasing operating losses.
The future of NOTV hinges on the outcomes of its restructuring efforts and how it addresses the delisting notice from Nasdaq. Additionally, the performance of sector bellwethers will be critical in determining the overall momentum in the Healthcare sector.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Newly stated in 2026-Q2. The Company filed voluntary Chapter 11 petitions on June 3, 2026, as disclosed in the 8-K filing. Revenue declined from $138.1M in 2025-Q4 to $117.7M in 2026-Q2, with operating losses increasing to -$19.3M in 2026-Q2. The trajectory shows significant financial distress leading to the restructuring priority.
“On June 3, 2026, the Company and certain subsidiaries filed voluntary petitions commencing cases under Chapter 11 of the United States Bankruptcy Code.”
Breaks if: EPS remains below -$1.00 in FY27
Breaks if: Inability to meet financial obligations or further acceleration of debt
Implement the prepackaged plan and manage debt and creditor claims during bankruptcy proceedings.
Newly stated in 2026-Q2. The Company disclosed entering into a Restructuring Support Agreement and filing a prepackaged plan to manage financial obligations. Operating income declined from -$6.8M in 2025-Q4 to -$19.3M in 2026-Q2, reflecting financial pressures. The priority aligns with the need to manage debt through bankruptcy.
“The Company filed a prepackaged Chapter 11 plan and entered into a Restructuring Support Agreement with lenders and creditors.”
Breaks if: Failure to regain Nasdaq compliance leading to delisting
Respond to Nasdaq's determination to delist the Company's common shares due to Chapter 11 filing.
Newly stated in 2026-Q2. The delisting notice followed the Chapter 11 filing in June 2026. Financials show declining revenue and increasing losses in 2026-Q2, consistent with the regulatory challenges. The priority reflects the Company's need to address listing compliance amid restructuring.
“Nasdaq determined to delist the Company’s common shares due to the commencement of voluntary Chapter 11 proceedings.”
In the next 1 to 3 years, NOTV faces significant challenges that will require careful monitoring of its restructuring progress and sector dynamics. Not investment advice.